Abstract
BackgroundThe RAPID-PsA trial (NCT01087788) investigated the efficacy and safety of certolizumab pegol (CZP) in patients (pts) with psoriatic arthritis (PsA). It demonstrated that CZP treatment inhibits radiographic progression over 96...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have